Janssen-Cilag S.A., Edificio Johnson & Johnson
Records under this name other than patents Janssen-Cilag S.A., Edificio Johnson & Johnson holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Janssen-Cilag S.A., Edificio Johnson & Johnson
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,906,921 | 4-Alkoxypyridazine Derivatives as Fast Dissociating Dopamine 2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,933,101 | Thia(DIA)zoles as Fast Dissociating Dopamine 2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,895,562 | PIPERAZIN-1-YL-TRIFLUOROMETHYL-SUBSTITUTED-PYRIDINES as Fast Dissociating Dopamine 2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,852,554 | Radiolabelled PDE10 ligands Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,859,543 | IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,530,474 | Substituted 6-(1-Piperazinyl)-PYRIDAZINES as 5-HT6 Receptor Antagonists Formerly held Lapsed on the fee record Ended Sep 10, 2025 · High confidence | Lapsed on the fee record | Ended Sep 10, 2025 | High confidence |
| US 7,476,662 | Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine Term ended Term ended Jul 30, 2023 · From the USPTO record | Term ended | Term ended Jul 30, 2023 | From the USPTO record |
| US 9,012,448 | 1,2,4-Triazolo[4,3-a]pyridine Derivatives and Their Use as Positive Allosteric Modulators of MGLUR2 Receptors Lapsed on the fee record Ended Apr 21, 2023 · High confidence | Lapsed on the fee record | Ended Apr 21, 2023 | High confidence |
| US 9,174,953 | Bicyclic Thiazoles as Allosteric Modulators of MGLUR5 Receptors Formerly held Lapsed on the fee record Ended Nov 3, 2019 · High confidence | Lapsed on the fee record | Ended Nov 3, 2019 | High confidence |
| US 9,040,707 | Bicyclic Thiazoles as Allosteric Modulators of MGLUR5 Receptors Formerly held Lapsed on the fee record Ended May 26, 2019 · High confidence | Lapsed on the fee record | Ended May 26, 2019 | High confidence |